Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2.
Saved in:
| Title: | Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2. |
|---|---|
| Authors: | Pusceddu, Sara1 (AUTHOR) sara.pusceddu@istitutotumori.mi.it, Corti, Francesca1,2 (AUTHOR), Prinzi, Natalie1 (AUTHOR), Nichetti, Federico1 (AUTHOR), Ljevar, Silva3 (AUTHOR), Busico, Adele4 (AUTHOR), Cascella, Tommaso5 (AUTHOR), Leporati, Rita1 (AUTHOR), Oldani, Simone1 (AUTHOR), Pircher, Chiara Carlotta1 (AUTHOR), Coppa, Jorgelina6 (AUTHOR), Resi, Veronica7 (AUTHOR), Milione, Massimo8 (AUTHOR), Maccauro, Marco9 (AUTHOR), Miceli, Rosalba3 (AUTHOR), Tamborini, Elena4 (AUTHOR), Perrone, Federica4 (AUTHOR), Spreafico, Carlo5 (AUTHOR), Niger, Monica1 (AUTHOR), Morano, Federica1 (AUTHOR) |
| Source: | Journal of Hematology & Oncology. 12/14/2023, Vol. 16 Issue 1, p1-5. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17568722 |
|---|---|
| DOI: | 10.1186/s13045-023-01510-9 |
